Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROVE IT-TIMI 22
NCT00382460Phase 4Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Nov 2000
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
Phase 4, randomised, double-blind trial of atorvastatin and gatifloxacin in acute coronary syndrome (ACS) (4 arms), sponsored by Bristol Myers Squibb. Primary endpoint: Death or Major Cardiovascular Event at 2 years. Started Nov 2000; status: completed.
02
Drugs
atorvastatingatifloxacin
03
Conditions
acute coronary syndrome (ACS)
Beyond the preview
Go deeper on NCT00382460.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00382460.